| Detected | Trial | Change |
|---|---|---|
| 2026-08-12 | NCT06496620 A Study to Evaluate Solrikitug in Participants With COPD (ZION) |
Enrollment closed, study ongoing |
| 2026-08-12 | NCT06496620 A Study to Evaluate Solrikitug in Participants With COPD (ZION) |
Trial sites reduced: 118 -> 110 locations |
| 2026-08-12 | NCT06496620 A Study to Evaluate Solrikitug in Participants With COPD (ZION) |
date change Primary completion pushed: 2026-06-30 -> 2026-09-30 |
| 2026-08-12 | NCT06496620 A Study to Evaluate Solrikitug in Participants With COPD (ZION) |
date change Completion pushed: 2026-10-31 -> 2027-02-01 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT06598462 | A Study to Investigate the Efficacy and Safety of NSI-8226 in Adults With Eosinophilic… | Eosinophilic Esophagitis (EoE) | Active, Not Recruiting |
| NCT06496607 | A Study to Evaluate Solriktug in Adult Participants With Asthma | Asthma | Active, Not Recruiting |
| NCT06496620 | A Study to Evaluate Solrikitug in Participants With COPD (ZION) | COPD | Active, Not Recruiting |